Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide...
This is a discussion on Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide... within the News and Hot Topics such as Hepatitis C, SARS and AIDS forum; Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide™ Increased Hemoglobin In Dialysis ...
noblood Home 
General
News and Hot Topics such as Hepatitis C, SARS and AIDS
Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide...
| Notices |
Welcome to the latest in bloodless medicine and blood transfusion alternatives.
We are a community of medical professionals and members of the public who are responding to the worldwide concern about the efficacy, cost and availability of donor blood. |
|
|
|
LinkBack | Thread Tools | Search this Thread | Rate Thread | Display Modes |
 |
11-02-2009, 09:59 PM
|
||||
|
||||
|
Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide...
Affymax And Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide™ Increased Hemoglobin In Dialysis Patients
Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Global Research & Development Center, Inc., announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients. This is the first reported data from an open-label, controlled comparative study of once-monthly Hematide compared to three times per week epoetin alfa (EPO). More
__________________
Sharon Grant Editorial Team     
|
| The Following User Says Thank You to Sharon Grant For This Useful Post: | ||
Bob Jordan (11-03-2009) | ||
| sponsor links |
|
| Tags |
| affymax, anemic, dialysis, dialysis patients, epo, epoetin alfa, hematide, hemoglobin, takeda, trial |
| sponsor links |
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
Linear Mode
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Affymax to Highlight Hematide Data at the American Society of Nephrology Renal Week.. | Sharon Grant | News and Hot Topics such as Hepatitis C, SARS and AIDS | 0 | 10-23-2009 10:04 PM |
| donation and transfusion data | Ken Stahorsky | Ask a Professional | 3 | 11-22-2008 12:58 AM |
| National data re: TKA and THA transfusion | alkiremr | Ask a Professional | 0 | 05-10-2007 01:37 PM |
| Tonsillectomy using the Ligasure vessel sealing system. A preliminary report. | Sharon Grant | Medical Conditions and Treatments | 0 | 07-19-2006 09:26 PM |
| Data on TissueLink Bipolar sealer | Julie Cade | Ask a Professional | 4 | 10-28-2005 10:44 AM |
